Mutated DNA in the stool - Does it have a role in colorectal cancer screening?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 3, Issue 11, 2006, Pages 594-595

  Half, Elizabeth E ^a   Lynch, Patrick M ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; DNA; K RAS PROTEIN; PROTEIN MSH2; PROTEIN P53; RAS PROTEIN;

BARIUM ENEMA; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COST EFFECTIVENESS ANALYSIS; FALSE NEGATIVE RESULT; FECES ANALYSIS; HUMAN; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; NON INVASIVE PROCEDURE; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SIGMOIDOSCOPY;

COLON; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; FECES; HUMANS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

EID: 33750466185     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0652     Document Type: Review

References (10)

1. Jemal A (2006) Cancer Statistics, 2006. CA Cancer J Clin 56: 106-130
2. National Comprehensive Cancer Network (2006) National Guideline Clearinghouse [http://www.guidelines.gov] (accessed 20 August 2006)
3. Ouyang DL et al. (2005): Noninvasive Aesting for colorectal cancer: a review. Am J Gastroenterol 100: 1393-1403
4. Fletcher JG et al. (2004) CT colonography: Unraveling the twists and turns. Curr Opin Gastroenterol 21: 90-98
5. Sidransky D et al. (1992) Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105
6. Traverso G et al. (2002) Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 346: 311-320
7. Ahlquist DA et al. (2000) Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel. Gastroenterology 119: 1219-1227
8. Imperiale TF et al. (2004) Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Engl J Med 351: 2704-2714
9. Brenner DE and Rennert G (2005) Fecal DNA biomarkers for the detection of colorectal neoplasia: Attractive, but is it feasible. J Natl Can Inst 97: 1107-1109
10. Song KA et al. (2004) Fecal DNA testing compared with conventional colorectal cancer screening methods: A decision analysis. Gastroenterology 126: 1270-1279